Citation Impact
Citing Papers
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Identification of the renal erythropoietin-producing cells using transgenic mice
1993 StandoutNobel
pVHL Acts as an Adaptor to Promote the Inhibitory Phosphorylation of the NF-κB Agonist Card9 by CK2
2007 StandoutNobel
The von Hippel–Lindau Tumor Suppressor Gene
2001 StandoutNobel
The von Hippel–Lindau tumor suppressor protein
2001 StandoutNobel
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
2003 StandoutNobel
Sites of erythropoietin production
1997 StandoutNobel
Respiratory Arrest in near-Fatal Asthma
1991 Standout
von Hippel-Lindau Disease
1997 StandoutNobel
The interstitial response to renal injury: Fibroblast–like cells show phenotypic changes and have reduced potential for erythropoietin gene expression
1997 StandoutNobel
From Erythropoietin to Oxygen: Hypoxia-Inducible Factor Hydroxylases and the Hypoxia Signal Pathway
2002 StandoutNobel
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
1994 StandoutNobel
Pharmacologic Modulation of Erythropoietin Production
1988
Molecular biology of erythropoietin
1993 StandoutNobel
Tumour suppression by the human von Hippel-Lindau gene product
1995 StandoutNobel
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
2005 StandoutNobel
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Organ distribution of erythropoietin messenger RNA in normal and uremic rats
1991 StandoutNobel
Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements
2001
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
1989
EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
1986 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Renal innervation plays no role in oxygen-dependent control of erythropoietin mRNA levels
1992 StandoutNobel
Renal erythropoietin: Properties and production
2006
Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements.
1990 StandoutNobel
von Hippel-Lindau Disease
2006 StandoutNobel
Neuromuscular manifestations of electrolyte disorders
1982
Polycythemia: Mechanisms and Management
1981
Regulation of Erythropoietin Production: New Insights Into Molecular Mechanisms of Oxygen Homeostasis
1994 StandoutNobel
Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells
1994 StandoutNobel
Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.
1991 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Human Erythropoietin Gene Expression in Transgenic Mice: Multiple Transcription Initiation Sites and cis-Acting Regulatory Elements
1990 StandoutNobel
Oxygen Sensing and Homeostasis
2015 StandoutNobel
Anemia of end-stage renal disease (ESRD)
1985
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
2017 StandoutNobel
Polycythemia in transgenic mice expressing the human erythropoietin gene.
1989 StandoutNobel
Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing.
2001 StandoutNobel
Phorbol ester inhibits erythropoietin production in human hepatoma cells (Hep G2)
1992 StandoutNobel
Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care Organization
2004 Standout
Erythropoietin levels in uremic nephric and anephric patients.
1979
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.
1984
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
1984
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
1987 Standout
Erythrocytosis in Patients on Long-term Hemodialysis
1982
Works of Andrew Ma being referenced
Effect of parathyroid hormone on erythropoiesis.
1981
A clinical trial of prostaglandin E2 to increase erythropoiesis in anemia of end stage renal disease. A preliminary report
1984
Exceptionally high serum erythropoietin activity in an anephric patient with severe anemia
1977
A Beneficial Effect of the <i>in situ </i>Kidney on <i>in vitro </i>Marrow Erythropoiesis in Chronic Renal Failure
1979